# CytomX Therapeutics, Inc.: Form 8-K, filed Jun 17, 2024

- Company: [CytomX Therapeutics, Inc.](/companies/ctmx.md) (CIK 1501989)
- Form: 8-K
- Filed: 2024-06-17
- Accepted by EDGAR: Jun 17, 2024, 16:35 ET
- Period: 2024-06-12
- Accession: 0001193125-24-162652
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1501989/000119312524162652/d831468d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1501989/000119312524162652/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1501989/000119312524162652/d831468d8k.htm

Filed Jun 17, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-162652. Last ingested by Listed: Nov 10, 2026, 16:48 ET. No prices; not investment advice.
